iifl-logo

Remus Pharmaceuticals Ltd Board Meeting

Add as a Preferred Source on Google
760.85
(-5.48%)
May 22, 2026|05:30:00 AM

Remus Pharma. CORPORATE ACTIONS

24/05/2025calendar-icon
24/05/2026calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting20 May 202613 May 2026
Financial Results/Dividend/Other business matters Remus Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 20, 2026, recommended Final Dividend of Rs. 0.50 per equity share. (As Per NSE Announcement Dated on:20.05.2026)
Board Meeting10 Nov 20251 Nov 2025
To consider and approve the financial results for the period ended September 30, 2025, dividend and other business matters Remus Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025. (As Per NSE Announcement Dated On : 10.11.2025)
Board Meeting29 Aug 202529 Aug 2025
Remus Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 29, 2025.
Board Meeting7 Jul 20257 Jul 2025
Remus Pharmaceuticals Limited has informed the Exchange regarding allotment of 5892000 securities pursuant to Bonus at its meeting held on July 07, 2025
Board Meeting20 Jun 202520 Jun 2025
Remus Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on June 20, 2025.

Remus Pharma.: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.